Ken Inoki
Impact in
- Aging top 0.5%
- Molecular Biology top 0.2%
- PI3K/AKT/mTOR signaling in cancer
- Metabolism, Diabetes, and Cancer
- Polyamine Metabolism and Applications
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 51
- Polyamine Metabolism and Applications 20
- Metabolism, Diabetes, and Cancer 11
- Physiology 22
- Tuberous Sclerosis Complex Research 15
- Co-authors
- Kun‐Liang Guan (35 shared papers)Tianqing Zhu (3 shared papers)Yong Li (6 shared papers)Jun Wu (1 shared paper)Tianquan Zhu (1 shared paper)Michael N. Corradetti (3 shared papers)Tian Xu (1 shared paper)Tsuneo Ikenoue (9 shared papers)
- Journals
- Journal of Biological Chemistry (9 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of the American Society of Nephrology (4 papers)The EMBO Journal (3 papers)Genes & Development (3 papers)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Ken Inoki
92 papers receiving 17.9k citations
Ken Inoki's Hit Papers
Peers
Comparison fields: 5 of 140
- Aging 454
- Molecular Biology 12.2k
- Geriatrics and Gerontology 463
- Physiology 662
- Cell Biology 2.3k
Countries citing papers authored by Ken Inoki
This map shows the geographic impact of Ken Inoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Inoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Inoki more than expected).
Fields of papers citing papers by Ken Inoki
This network shows the impact of papers produced by Ken Inoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Inoki. The network helps show where Ken Inoki may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Inoki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival Hit paper breakdown → | 2003 | 3147 |
| 2 | TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Hit paper breakdown → | 2002 | 2438 |
| 3 | Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling Hit paper breakdown → | 2003 | 1487 |
| 4 | TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth Hit paper breakdown → | 2006 | 1091 |
| 5 | Dysregulation of the TSC-mTOR pathway in human disease Hit paper breakdown → | 2004 | 779 |
| 6 | AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets Hit paper breakdown → | 2011 | 640 |
| 7 | ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS Hit paper breakdown → | 2010 | 586 |
| 8 | 2008 | 497 | |
| 9 | Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes Hit paper breakdown → | 2011 | 464 |
| 10 | 2004 | 454 | |
| 11 | mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice Hit paper breakdown → | 2011 | 442 |
| 12 | 2006 | 403 | |
| 13 | 2005 | 265 | |
| 14 | 2012 | 222 | |
| 15 | 2008 | 201 | |
| 16 | 2004 | 200 | |
| 17 | 2005 | 196 | |
| 18 | 2013 | 191 | |
| 19 | 2019 | 182 | |
| 20 | 2006 | 176 |
About Ken Inoki
Ken Inoki is a scholar working on Molecular Biology, Physiology, Cell Biology, Epidemiology and Immunology, having authored 94 papers that have together received 18.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (51 papers), Polyamine Metabolism and Applications (20 papers), Tuberous Sclerosis Complex Research (15 papers), Cellular transport and secretion (12 papers), Autophagy in Disease and Therapy (12 papers), Metabolism, Diabetes, and Cancer (11 papers), Mast cells and histamine (9 papers) and Pancreatic function and diabetes (8 papers). The work is most often cited by research in Aging (454 citations), Molecular Biology (12.2k citations), Geriatrics and Gerontology (463 citations), Physiology (662 citations) and Cell Biology (2.3k citations). Ken Inoki has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Kun‐Liang Guan, Tianqing Zhu, Yong Li, Jun Wu, Tianquan Zhu, Michael N. Corradetti, Tian Xu, Tsuneo Ikenoue, Qian Yang and Joungmok Kim. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of the American Society of Nephrology, The EMBO Journal and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.